Beyond Cobi+Reg, our expanded HTDS screen identified several intriguing combinations, including MEK inhibitors and angiogenesis inhibitors, reinforcing the importance of these pathways to the survival of ICB-resistant melanoma. The gene discussed is MAP2K7; the disease is melanoma.